XAVi Technologies Corporation (3447) Fair Value & Analysis
Technology · TW · Market cap 3.1B TWD
Fair value as of: Jun 24, 2026
Analysis
XAVi Technologies Corporation (3447) currently trades at 39.40 TWD, while our model-based Fair Value estimate is 28.07 TWD — implying the stock looks roughly 28.8% overvalued today. We read business quality at 95/100 (high quality), in the Technology sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
About the company
XAVi Technologies Corporation, together with its subsidiaries, engages in the research, development, manufacture, and sale of networking communication products in Taiwan and the rest of Asia. The company offers broadband access products, including active ethernet, GPON, G.fast 212 single port DPU, and G.fast 106/212 CPE; short and middle range internet of things products for commercial, industrial, consumer, human-to-machine, and machine-to-machine applications; Wi-Fi access point and wi-fi PTP/PMP products; and multimedia products. It is also involved in overseas investment activities. The company serves the telecommunication, enterprise, small business, SOHO, and family and general household networking markets. XAVi Technologies Corporation was incorporated in 1997 and is headquartered in New Taipei City, Taiwan.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is XAVi Technologies Corporation (3447) undervalued?
What is the fair value of 3447?
What is the quality score of 3447?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.